Variant report
Variant | nsv1030174 |
---|---|
Chromosome Location | chr6:23743412-23776497 |
allele | n/a |
Outlinks | Ensembl   UCSC |
- TF binding region (count:0)
- CpG islands (count:0)
- Chromatin interactive region (count:3)
- LncRNA region (count:0)
- Mature miRNA region (count: 0)
- miRNA target sites (count:0)
No data |
No data |
(count:3 , 50 per page) page:
1
No data |
No data |
No data |
Variant related genes | Relation type |
---|---|
ENSG00000108395 | chromatin interactions |
ENSG00000224738 | chromatin interactions |
No. | Variant name | Chromosome position | Chromatin state | Related regulatory elements | Target genes | Extended variants | Associated traits |
---|---|---|---|---|---|---|---|
1 | rs28561416 | chr6:23747404-23747405 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
2 | rs189670909 | chr6:23747451-23747452 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
3 | rs181141962 | chr6:23747452-23747453 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
4 | rs547646539 | chr6:23747477-23747478 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
5 | rs565860165 | chr6:23747479-23747480 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
6 | rs539563853 | chr6:23747502-23747503 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
7 | rs367863912 | chr6:23747526-23747527 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
8 | rs576000512 | chr6:23747538-23747539 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
9 | rs558954854 | chr6:23747544-23747545 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
10 | rs186132625 | chr6:23747545-23747546 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
11 | rs574350260 | chr6:23747575-23747576 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
12 | rs545281209 | chr6:23747599-23747600 | Enhancers | Chromatin interactive region | 2 gene(s) | Overlapped CNVs | n/a |
13 | rs143087970 | chr6:23747665-23747666 | Enhancers | Chromatin interactive region | 2 gene(s) | Overlapped CNVs | n/a |
14 | rs575073710 | chr6:23747680-23747681 | Enhancers | Chromatin interactive region | 2 gene(s) | Overlapped CNVs | n/a |
15 | rs147071806 | chr6:23747681-23747682 | Enhancers | Chromatin interactive region | 2 gene(s) | Overlapped CNVs | n/a |
16 | rs1886562 | chr6:23747732-23747733 | Enhancers | Chromatin interactive region | 2 gene(s) | LD-proxies of rSNPOverlapped rCNV | mRNA abundance |
17 | rs572399909 | chr6:23747744-23747745 | Enhancers | Chromatin interactive region | 2 gene(s) | Overlapped CNVs | n/a |
18 | rs138125944 | chr6:23747766-23747767 | Enhancers | Chromatin interactive region | 2 gene(s) | Overlapped CNVs | n/a |
19 | rs564383055 | chr6:23747822-23747823 | Enhancers | Chromatin interactive region | 2 gene(s) | Overlapped CNVs | n/a |
20 | rs149562988 | chr6:23747825-23747826 | Enhancers | Chromatin interactive region | 2 gene(s) | Overlapped CNVs | n/a |
21 | rs549954354 | chr6:23747836-23747837 | Enhancers | Chromatin interactive region | 2 gene(s) | Overlapped CNVs | n/a |
22 | rs1886563 | chr6:23747837-23747838 | Enhancers | Chromatin interactive region | 2 gene(s) | LD-proxies of rSNPOverlapped rCNV | n/a |
23 | rs34603475 | chr6:23747852-23747853 | Enhancers | Chromatin interactive region | 2 gene(s) | Overlapped CNVs | n/a |
24 | rs577402077 | chr6:23747853-23747854 | Enhancers | Chromatin interactive region | 2 gene(s) | Overlapped CNVs | n/a |
25 | rs200347754 | chr6:23747860-23747861 | Enhancers | Chromatin interactive region | 2 gene(s) | Overlapped CNVs | n/a |
26 | rs77655614 | chr6:23747862-23747863 | Enhancers | Chromatin interactive region | 2 gene(s) | Overlapped CNVs | n/a |
27 | rs75261934 | chr6:23747863-23747864 | Enhancers | Chromatin interactive region | 2 gene(s) | Overlapped CNVs | n/a |
28 | rs78409865 | chr6:23747864-23747865 | Enhancers | Chromatin interactive region | 2 gene(s) | Overlapped CNVs | n/a |
29 | rs78266897 | chr6:23747865-23747866 | Enhancers | Chromatin interactive region | 2 gene(s) | Overlapped CNVs | n/a |
30 | rs547687070 | chr6:23747882-23747883 | Enhancers | Chromatin interactive region | 2 gene(s) | Overlapped CNVs | n/a |
31 | rs34198800 | chr6:23747890-23747891 | Enhancers | Chromatin interactive region | 2 gene(s) | Overlapped CNVs | n/a |
32 | rs565900011 | chr6:23747895-23747896 | Enhancers | Chromatin interactive region | 2 gene(s) | Overlapped CNVs | n/a |
33 | rs1886564 | chr6:23747898-23747899 | Enhancers | Chromatin interactive region | 2 gene(s) | LD-proxies of rSNPOverlapped rCNV | n/a |
34 | rs551506081 | chr6:23747909-23747910 | Enhancers | Chromatin interactive region | 2 gene(s) | Overlapped CNVs | n/a |
35 | rs188891324 | chr6:23747914-23747915 | Enhancers | Chromatin interactive region | 2 gene(s) | Overlapped CNVs | n/a |
36 | rs77542244 | chr6:23747929-23747930 | Enhancers | Chromatin interactive region | 2 gene(s) | Overlapped CNVs | n/a |
37 | rs181595553 | chr6:23747950-23747951 | Enhancers | Chromatin interactive region | 2 gene(s) | Overlapped CNVs | n/a |
38 | rs555105132 | chr6:23747951-23747952 | Enhancers | Chromatin interactive region | 2 gene(s) | Overlapped CNVs | n/a |
39 | rs573557373 | chr6:23747967-23747968 | Enhancers | Chromatin interactive region | 2 gene(s) | Overlapped CNVs | n/a |
40 | rs535766410 | chr6:23747980-23747981 | Enhancers | Chromatin interactive region | 2 gene(s) | Overlapped CNVs | n/a |
41 | rs187389204 | chr6:23747984-23747985 | Enhancers | Chromatin interactive region | 2 gene(s) | Overlapped CNVs | n/a |
42 | rs562640749 | chr6:23747995-23747996 | Enhancers | Chromatin interactive region | 2 gene(s) | Overlapped CNVs | n/a |
43 | rs80300371 | chr6:23748011-23748012 | Enhancers | Chromatin interactive region | 2 gene(s) | Overlapped CNVs | n/a |
44 | rs192234264 | chr6:23748027-23748028 | Enhancers | Chromatin interactive region | 2 gene(s) | Overlapped CNVs | n/a |
45 | rs79516855 | chr6:23748030-23748031 | Enhancers | Chromatin interactive region | 2 gene(s) | Overlapped CNVs | n/a |
46 | rs144097581 | chr6:23748043-23748044 | Enhancers | Chromatin interactive region | 2 gene(s) | Overlapped CNVs | n/a |
47 | rs182695343 | chr6:23748050-23748051 | Enhancers | Chromatin interactive region | 2 gene(s) | Overlapped CNVs | n/a |
48 | rs561961315 | chr6:23748053-23748054 | Enhancers | Chromatin interactive region | 2 gene(s) | Overlapped CNVs | n/a |
49 | rs529270952 | chr6:23748068-23748069 | Enhancers | Chromatin interactive region | 2 gene(s) | Overlapped CNVs | n/a |
50 | rs547723729 | chr6:23748086-23748087 | Enhancers | Chromatin interactive region | 2 gene(s) | Overlapped CNVs | n/a |
Disease | PMID | Source |
---|---|---|
Colorectal cancer | 21297112 | CNVD |
Acute lymphoblastic leukemia | 22237106 | CNVD |
Follicular lymphoma | 20505157 | CNVD |
Glioblastoma multiforme | 21080181 | CNVD |
Ewing''s sarcoma | 21437220 | CNVD |
Basal cell lymphoma | 16317097 | CNVD |
Diffuse large b-cell lymphoma | 16317097 | CNVD |
Leukemia | 21518781 | CNVD |
Cancer | 21637783 | CNVD |
Facial dysmorphism | 22105932 | CNVD |
Medulloblastoma | 21979893 | CNVD |
Non-syndromic sensorineural hearing loss | 18471307 | CNVD |
Diffuse large b-cell lymphoma | 18287131 | CNVD |
Esophageal squamous carcinoma | 21637470 | CNVD |
Glioblastoma multiforme | 19960244 | CNVD |
Hepatocellular carcinoma | 22174799 | CNVD |
Endometrial cancer | 22040021 | CNVD |
Acute myeloid leukemia | 16864856 | CNVD |
Breast cancer | 21264507 | CNVD |
Acute lymphoblastic leukemia | 20067559 | CNVD |
Cancer | 16751803 | CNVD |
Bladder cancer | 19088036 | CNVD |
Wilms tumour | 21544195 | CNVD |
Uveal melanoma | 21693616 | CNVD |
Biliary cancer | 19435499 | CNVD |
Malaria | 21533027 | CNVD |
Retinoblastoma | 19183342 | CNVD |
Acute myeloid leukemia | 20729466 | CNVD |
T-cell prolymphocytic leukemia | 19278963 | CNVD |
Breast cancer | 20668451 | CNVD |
Cancer | 20668451 | CNVD |
Lung cancer | 20668451 | CNVD |
Ovarian cancer | 20668451 | CNVD |
Pancreas cancer | 20668451 | CNVD |
Prostate cancer | 20668451 | CNVD |
Acute lymphoblastic leukemia | 20435627 | CNVD |
Prostate cancer | 18632612 | CNVD |
Myelodysplastic syndrome | 21251322 | CNVD |
Breast cancer | 21858162 | CNVD |
Lung cancer | 18438408 | CNVD |
Multiple myeloma | 17550852 | CNVD |
Ewing''s sarcoma | 17952124 | CNVD |
Gastric cancer | 16891809 | CNVD |
Ovarian cancer | 21781307 | CNVD |
Autism | 21448237 | CNVD |
Cancer | 20164919 | CNVD |
Melanoma | 18172304 | CNVD |
Breast cancer | 22844521 | CNVD |
HIV/AIDS | 22844521 | CNVD |
Ovarian cancer | 22844521 | CNVD |
Prostate cancer | 22844521 | CNVD |
Psoriasis | 22844521 | CNVD |
Rheumatoid arthritis | 22844521 | CNVD |
Sclerosis systemic | 22844521 | CNVD |
Systemic lupus erythematosus | 22844521 | CNVD |
Breast cancer | 22522925 | CNVD |
Breast cancer | 21552322 | CNVD |
Immune disease | 21076436 | CNVD |
Autoimmune disease | 19135723 | CNVD |
Systemic lupus erythematosus | 17953491 | CNVD |
Recurrent Infections | 22737222 | CNVD |
Systemic lupus erythematosus | 21904924 | CNVD |
Ependymoma | 19289631 | CNVD |
Gestational infection | 22844521 | CNVD |
Head circumference | 22844521 | CNVD |
Infertility | 22844521 | CNVD |
Recurrent birth weight diabetes | 22844521 | CNVD |
Obesity | 22844521 | CNVD |
Recurrent pregnancy loss | 22844521 | CNVD |
Intellectual disability | 21811512 | CNVD |
Chronic lymphocytic leukemia | 21546498 | CNVD |
Congenital anomalies of the kidney and urinary tract | 18694510 | CNVD |
Nasopharyngeal cancer | 22815911 | CNVD |
Osteosarcoma | 16790693 | CNVD |
Hepatocellular carcinoma | 16750200 | CNVD |
Basal cell lymphoma | 21115979 | CNVD |
Acute lymphoblastic leukemia | 21339820 | CNVD |
Ovarian cancer | 21720365 | CNVD |
Breast cancer | 17133270 | CNVD |
Autism | 22495311 | CNVD |
Burkitt''s lymphoma | 19759907 | CNVD |
T-cell prolymphocytic leukemia | 17713554 | CNVD |
Hodgkin''s lymphoma | 17606441 | CNVD |
Cancer | 16790693 | CNVD |
Breast cancer | 22032731 | CNVD |
Cervical cancer | 21062161 | CNVD |
Breast cancer | 21785460 | CNVD |
Bladder cancer | 16790693 | CNVD |
Oral squamous cell carcinoma | 17134496 | CNVD |
Retinoblastoma | 16790693 | CNVD |
Esophageal adenocarcinoma | 18820669 | CNVD |
Systemic lupus erythematosus | 17503323 | CNVD |
Endometrioid adenocarcinoma | 16974079 | CNVD |
T-cell lymphomas | 19863542 | CNVD |
Urothelial carcinoma | 18382360 | CNVD |
Lung cancer | 19153074 | CNVD |
Breast cancer | 21364760 | CNVD |
Cancer | 21183584 | CNVD |
small cell lung cancer | 20016488 | CNVD |
Myelofibrosis | 22110671 | CNVD |
Williams-beuren syndrome | 16971481 | CNVD |
Uveal melanoma | 20484589 | CNVD |
No. | Chromosome Location | Chromatin state | Cell line | Tissue |
---|---|---|---|---|
1 | chr6:23747400-23748200 | Enhancers | H9 Derived Neuron Cultured Cells | ES cell derived |
2 | chr6:23752800-23753600 | Enhancers | Fetal Kidney | kidney |
3 | chr6:23756800-23757400 | Active TSS | Fetal Heart | heart |
4 | chr6:23774000-23774600 | Enhancers | hESC Derived CD56+ Mesoderm Cultured Cells | ES cell derived |
5 | chr6:23774600-23774800 | Enhancers | Rectal Smooth Muscle | rectum |
6 | chr6:23774600-23775000 | Enhancers | HUES48 Cell Line | embryonic stem cell |
7 | chr6:23774600-23775600 | Enhancers | hESC Derived CD184+ Endoderm Cultured Cells | ES cell derived |
8 | chr6:23775200-23775800 | Enhancers | iPS-18 Cell Line | embryonic stem cell |
9 | chr6:23775400-23775600 | Enhancers | Rectal Smooth Muscle | rectum |